Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic PBSC Transplant for Less Advanced MDS
NCT00024050Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Feb 2001
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of peripheral blood stem cells in myelodysplastic syndrome (MDS), sponsored by Fred Hutchinson Cancer Center. Started Feb 2001; status: completed.
02
Drugs
peripheral blood stem cells
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00024050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00024050.